GGrantIndex
← Leaderboards

Daniel A Dumesic

Mayo Clinic Coll Of Medicine, Rochester

$4,209,921
Attributed
$4,209,921
Total exposure
11
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $434.3K · FY200521
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$4,209,921 · 11

By mechanism

P50$2,325,185 · 2
U01$1,342,194 · 1
P51$220,860 · 5
U54$214,492 · 1
R21$107,190 · 1
M01$0 · 1

Top collaborators

No co-investigators on record.

Most similar at Mayo Clinic Coll Of Medicine, Rochester

Same institution · by research overlap

Others in their field

Top investigators on “Female

Research focus

FemalePolycystic Ovary SyndromeAndrogensInfertilityHyperandrogenismParacrineMacaca MulattaWomanInsulin ResistanceLipid BiosynthesisFunctional DisorderLinkAbdomenGene ExpressionLipidsAndrogen AntagonistsAbdominal FatFatty Acid Glycerol EstersDietBody FatEnergy IntakeBmp4Adipose TissueAdipocytes

Grant awards (25)

Androgen Excess Causes Adipogenic Dysfunction in PCOS Women$273,757
P50 · FY2021 · HD · contact PI
Androgen Excess Causes Adipogenic Dysfunction in PCOS Women$289,152
P50 · FY2020 · HD · contact PI
Androgen Excess Causes Adipogenic Dysfunction in PCOS Women$290,620
P50 · FY2019 · HD · contact PI
Androgen Excess Causes Adipogenic Dysfunction in PCOS Women$289,657
P50 · FY2018 · HD · contact PI
PROJECT 4: ANDROGEN EXCESS IN ADIPOGENIC DYSFUNCTION IN PCOS WOMEN$296,644
P50 · FY2017 · HD · contact PI
PROJECT 4: ANDROGEN EXCESS IN ADIPOGENIC DYSFUNCTION IN PCOS WOMEN$282,442
P50 · FY2016 · HD · contact PI
PROJECT 4: ANDROGEN EXCESS IN ADIPOGENIC DYSFUNCTION IN PCOS WOMEN$275,849
P50 · FY2015 · HD · contact PI
PROJECT 4: ANDROGEN EXCESS IN ADIPOGENIC DYSFUNCTION IN PCOS WOMEN$327,064
P50 · FY2014 · HD · contact PI
PROJECT 4: ANDROGEN EXCESS IN ADIPOGENIC DYSFUNCTION IN PCOS WOMEN$214,492
U54 · FY2013 · HD · contact PI
PARACRINE DYSREGULATION OF OOCYTE COMPETENCE IN POLYCYSTIC OVARY SYNDROME$40,957
P51 · FY2008 · RR · contact PI
PARACRINE DYSREGULATION OF OOCYTE COMPETENCE IN POLYCYSTIC OVARY SYNDROME$62,967
P51 · FY2007 · RR · contact PI
Paracrine dysregulation of oocyte competence in PCOS$177,571
U01 · FY2006 · HD · contact PI
Paracrine dysregulation of oocyte competence in PCOS$42,984
U01 · FY2006 · HD · contact PI
PARACRINE DYSREGULATION OF OOCYTE COMPETENCE IN POLYCYSTIC OVARY SYNDROME$27,215
P51 · FY2006 · RR · contact PI
Paracrine dysregulation of oocyte competence in PCOS$399,464
U01 · FY2005 · HD
PARACRINE DYSREGULATION OF OOCYTE COMPETENCE IN PCOS$34,795
P51 · FY2005 · RR
Paracrine dysregulation of oocyte competence in PCOS$362,362
U01 · FY2004 · HD
Paracrine dysregulation of oocyte competence in PCOS$13,730
U01 · FY2004 · HD
PARACRINE DYSREGULATION OF OOCYTE COMPETENCE IN PCOS$572
P51 · FY2004 · RR
Paracrine dysregulation of oocyte competence in PCOS$346,083
U01 · FY2003 · HD
INHIBIN A &INHIBIN B AS MARKERS OF FOLLICULAR MATURITY DURING OVARIAN STIMULATIO$0
M01 · FY2002 · RR
INHIBIN A &INHIBIN B AS MARKERS OF FOLLICULAR MATURITY DURING OVARIAN STIMULATIO$0
M01 · FY2001 · RR
OOCYTE COMPETENCY IN PRENATALLY ANDROGENIZED ANIMALS$107,190
R21 · FY2000 · RR
OVARIAN STIMULATION &OOCYTE COMPETENCE IN PRENATALLY ANDROGENIZED FEMALE RHESUS$54,354
P51 · FY2000 · RR
INHIBIN A &INHIBIN B AS MARKERS OF FOLLICULAR MATURITY DURING OVARIAN STIMULATIO$0
M01 · FY2000 · RR